Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Apr 4, 2023
Date Accepted: Apr 30, 2023

The final, peer-reviewed published version of this preprint can be found here:

Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study

Nisa S, Vallee E, Marshall J, Collins-Emerson J, Yeung P, Prinsen G, Douwes J, Baker MG, Wright J, Quin T, Holdaway M, Wilkinson DA, Fayaz A, Littlejohn S, Benschop J

Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study

JMIR Res Protoc 2023;12:e47900

DOI: 10.2196/47900

PMID: 37289491

PMCID: 10288348

Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study

  • Shahista Nisa; 
  • Emilie Vallee; 
  • Jonathan Marshall; 
  • Julie Collins-Emerson; 
  • Polly Yeung; 
  • Gerard Prinsen; 
  • Jeroen Douwes; 
  • Michael G Baker; 
  • Jackie Wright; 
  • Tanya Quin; 
  • Maureen Holdaway; 
  • David A Wilkinson; 
  • Ahmed Fayaz; 
  • Stuart Littlejohn; 
  • Jackie Benschop

ABSTRACT

Background:

In Aotearoa New Zealand, 90% of cases with notified leptospirosis (a zoonotic bacterial disease) have been men working in agricultural industries. However, since 2008, the epidemiology of notified cases has gradually changed i.e., more women are affected, there are more cases associated with occupations traditionally not considered high-risk in New Zealand, infecting serovars have changed and many patients suffer long after infection. We hypothesise that there is a shift in leptospirosis transmission patterns with a significant burden on affected patients and their families.

Objective:

To describe the protocols used to conduct: 1) a nationwide case-control study to update leptospirosis risk factors; and 2) follow-up studies to assess the burden and sources of leptospirosis in New Zealand.

Methods:

The study used a mixed methods approach, comprising a case-control study, and four sub-studies that involved cases only. Cases were recruited nationwide, and controls were frequency matched by sex and rurality. All participants were administered a case-control questionnaire (Study 1), with cases being interviewed again at least 6 months after the initial survey (Study 2). A subset of cases from high-risk occupations i.e., farmers and abattoir workers, were further engaged in a semi-structured interview (Study 3). Some cases with regular animal exposure had their in-contact animals (livestock for blood and urine and wildlife for kidney) and environment (soil, mud, and water) sampled (Study 4). Patients from selected health clinics suspected of leptospirosis also had blood and urine samples taken (Study 5). Study 4 and 5 blood samples were tested with the microscopic agglutination test (MAT) to test for antibody titres against Leptospira serovars Hardjo type bovis, Ballum, Tarassovi, Pomona and Copenhageni. All blood, urine and environmental samples were also tested with polymerase chain reaction (PCR) analysis for the detection of pathogenic Leptospira DNA.

Results:

Participants were recruited between 22 July 2019 and 31 January 2022 and data collection for the study has concluded. Ninety-six cases and 300 controls were recruited and interviewed for the case control study, 92 cases participated in the follow-up interviews, 13 cases participated in the semi-structured interviews and 4 cases had their in-contact animals and environment sampled. Data analysis for the case-control study and the 6-month follow-up interviews are underway.

Conclusions:

The methods used in this study may provide a basis for future epidemiological studies for infectious disease. Clinical Trial: N/A


 Citation

Please cite as:

Nisa S, Vallee E, Marshall J, Collins-Emerson J, Yeung P, Prinsen G, Douwes J, Baker MG, Wright J, Quin T, Holdaway M, Wilkinson DA, Fayaz A, Littlejohn S, Benschop J

Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study

JMIR Res Protoc 2023;12:e47900

DOI: 10.2196/47900

PMID: 37289491

PMCID: 10288348

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.